Egypt · Delayed Price · Currency is EGP MINAPHARM Pharmaceuticals Company Description
MINAPHARM Pharmaceuticals produces medicines, chemicals, medical and dental supplies, cosmetics, veterinary and herbal medicines, and dietary supplements in Egypt and internationally.
It operates through Biological Production, Drug Production, and Other Pharmaceuticals segments. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease.
MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.
| Country | Egypt |
| Founded | 1958 |
| Industry | Pharmaceutical Preparations |
| Employees | 450 |
| CEO | Wafik El Bardissi |
Contact Details
Address: El-Bardissi Street Cairo Egypt | |
| Phone | 202 2414 3170 |
| Website | minapharm.com |
Stock Details
| Ticker Symbol | MIPH |
| Exchange | Egyptian Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wafik El Bardissi | Chief Executive Officer |
| Sameh George | Chief Financial Officer |